Adherium Annual Report
Link to Full Report
Adherium appoints Mr Geoff Feakes as Chief Technology Officer
/in AdheriumLink to Full Article Melbourne, Australia – 5 August 2020: Adherium Limited (ASX: ADR) a leader in digital inhaled device adherence, remote monitoring and data management solutions, has appointed Mr Geoff Feakes as Chief Technology Officer (CTO) leading the Company’s R&D and Innovation teams supporting Adherium’s revised business strategy. Mike Motion, Adherium CEO noted: “I […]
Cleansing notice under section 708A of the Corporations Act 2001 (Cth)
/in AdheriumLink to Full Article Adherium Limited ACN 605 352 510 (Company) (ASX: ADR) has undertaken an allotment of fully paid ordinary shares (Shares) under its Employee Share Plan. Details of the allotment are contained in the Appendix 2A filed by the Company on 30 June 2020. The Company gives notice pursuant to section 708A(5)(e) of […]
Adherium progresses U.S. sales agreement with respiratory device U.S. market leader Monaghan Medical Corporation, a member of the Trudell Medical Group of Companies
/in AdheriumLink to Full Article Melbourne, Australia – 29 April 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, has signed a heads of terms sales agreement with Monaghan Medical Corporation, a US subsidiary of Trudell Medical Limited, the parent company of a multinational group of leading companies […]
Adherium announces appointment of Mr. Mike Motion as Chief Executive Officer and Ms. Anne Bell as Chief Financial Officer
/in AdheriumLink to Full Article Melbourne, Australia – 24 April 2020: Adherium (ASX:ADR) today announced the promotion of Mr Mike Motion from Chief Operating Officer to the role of Chief Executive Officer, replacing Mr Jeremy Curnock Cook who has held the position on an interim basis. Mike will also join the Board as an Executive Director, […]
Adherium and Planet Innovation partner to develop inhaled medication adherence devices and enhanced digital software platform
/in AdheriumLink to Full Article Melbourne, Australia – 21 April 2020: Adherium (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, today announced a strategic device hardware and software development partnership with Planet Innovation (PI). This development will enhance Adherium’s leading device coverage position in both asthma and COPD with sensors […]
Adherium announces first US disease management collaboration in COPD with HGE Health
/in AdheriumLink to Full Article Melbourne, Australia – 16 April 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, has agreed a US disease management collaboration with Pennsylvania-based HGE Health. Both parties will rapidly evaluate and integrate Adherium’s sensor and software technology into HGE Health’s established telemedicine platform […]
Appointment of Mr. James Ward-Lilley as a Director and Chairman
/in AdheriumLink to Full Article 14 April 2020 – Adherium (ASX:ADR) announces that James Ward-Lilley who has been consulting to Adherium over recent months has joined the Adherium Board of Directors, and following the untimely death of Thomas Lynch, James has also been appointed Chairman of the Board. Mr. Ward-Lilley commented “I am pleased to be […]
Adherium announces death of Chairman, Thomas Lynch
/in AdheriumLink to Full Article 8 April 2020 – Adherium (ASX:ADR) announces with considerable sadness the unfortunate and untimely death of its Chairman, Thomas Lynch. Tom had been Chairman at Adherium since joining the Board in September 2016, and the Directors and staff of Adherium send their deepest condolences to Tom’s family at this very sad […]
Half Yearly Report and Accounts
/in AdheriumLink to Full Article Adherium Limited ABN 24 605 352 510 Appendix 4D Interim Consolidated Financial Report for the six months ended 31 December 2019 Adherium Limited (“Adherium”, the “Company” or the “Group”) presents this financial report, including the interim financial statements, for the six months ended 31 December Results for announcement […]